Loading

Proportion of 30-Day Prescriptions Filled with Brand-Name Products
  • Print
  • PDF
  • Embed

    Copy the following code and paste it into your website in order to display the current report.

  • Download to Excel

Customize Report

    • YEAR:

    Choose Locations

    [clear all] [select all] Selected Locations:

      Choose Indicator(s)

      Select one or more indicators
      • TOPIC:
      • INDICATOR:
      • YEAR:

      [clear all] Selected Indicators:

     

    Region
    (Click a region name
    below to view its profile)
    Proportion of 30-Day Prescriptions Filled with Brand-Name Products
    (Year: 2010; Region Levels: State)
    Alabama 24.7%
    Alaska 27.9%
    Arizona 26.8%
    Arkansas 23.5%
    California 29.3%
    Colorado 25.1%
    Connecticut 29.7%
    Delaware 29.6%
    District of Columbia 30.6%
    Florida 29.3%
    Georgia 26.5%
    Hawaii 32.2%
    Idaho 21.8%
    Illinois 24.9%
    Indiana 25.5%
    Iowa 19.6%
    Kansas 23.4%
    Kentucky 24.7%
    Louisiana 28.0%
    Maine 22.4%
    Maryland 28.1%
    Massachusetts 21.6%
    Michigan 21.4%
    Minnesota 19.0%
    Mississippi 26.1%
    Missouri 23.8%
    Montana 22.5%
    Nebraska 22.2%
    Nevada 25.6%
    New Hampshire 24.2%
    New Jersey 32.3%
    New Mexico 22.1%
    New York 31.8%
    North Carolina 26.4%
    North Dakota 20.8%
    Ohio 24.6%
    Oklahoma 25.8%
    Oregon 22.8%
    Pennsylvania 27.2%
    Rhode Island 24.5%
    South Carolina 28.1%
    South Dakota 21.3%
    Tennessee 24.4%
    Texas 28.3%
    Utah 23.7%
    Vermont 22.3%
    Virginia 25.7%
    Washington 22.3%
    West Virginia 24.7%
    Wisconsin 21.8%
    Wyoming 23.6%
    National Average 26.3%
    90th Percentile 29.7%
    50th Percentile 24.7%
    10th Percentile 21.4%
        • DENOMINATOR DEFINITION:
        • Prescription drug utilization and spending rates use a 40% Medicare random-sample denominator file for each year from 2006 to 2010. For the 2010 Part D enrollment cohort, patients were included if they (1) were age 65 or older as of 1/1/2010, (2) were alive and continuously enrolled in a stand-alone Medicare Part D plan for all 12 months of 2010, and (3) were not enrolled in hospice or a managed Medicare plan (Medicare Advantage) at any time during 2010.

        • NUMERATOR DEFINITION:
        • All medication use measures were based on Part D event fill records for the time frame specific to each cohort’s observation. The Lexi-Data Basic database (Lexicomp) was used to obtain the drug name, dose, brand or generic status, and active ingredient according to the National Drug Code (NDC).




    © 2018 Dartmouth Atlas of Health Care | 35 Centerra Parkway, Lebanon, NH 03766 | (603) 653-0800


    The Dartmouth Atlas of Health Care is based at The Dartmouth Institute for Health Policy and Clinical Practice and is supported by a coalition of funders led by the Robert Wood Johnson Foundation, including the WellPoint Foundation, the United Health Foundation, the California HealthCare Foundation, and the Charles H. Hood Foundation.


    The Dartmouth Institute for Health Policy & Clinical Practice Velir Datacenter Powered